Ranar Ciwon Suga ta Majalisar Dinkin Duniya | Hana Ciwon sukari, Inganta Lafiya

Ranar 14 ga Nuwamba, 2025, ita ce ranar Ciwon sukari ta Majalisar Dinkin Duniya karo na 19, tare da taken tallata "Ciwon Ciwon sukari da Lafiya". Yana jaddada sanya ingantaccen rayuwa ga mutanen da ke fama da ciwon sukari a cikin tushen sabis na kiwon lafiya na ciwon sukari, yana ba marasa lafiya damar jin daɗin rayuwar lafiya.

A duk duniya, kusan manya miliyan 589 (shekaru 20-79) suna da ciwon sukari, wanda ke wakiltar 11.1% (1 cikin 9) na wannan rukunin shekaru. Kimanin mutane miliyan 252 (43%) ba a gano su ba, suna fuskantar haɗarin rikitarwa. An yi hasashen adadin masu fama da ciwon sukari zai haura miliyan 853 nan da shekarar 2050, karuwar kashi 45%.

Etiology da Clinical Nau'in Ciwon sukari

Ciwon sukari jerin cututtuka ne na rashin lafiya na rayuwa wanda ya haɗa da sukari, furotin, mai, ruwa, da electrolytes, wanda ke haifar da abubuwa daban-daban na cututtuka kamar kwayoyin halitta, cututtuka na tsarin rigakafi, cututtuka na microbial da gubobinsu, daɗaɗɗen radicals, da abubuwan tunani da ke aiki a jiki. Wadannan abubuwan suna haifar da lalacewar aikin tsibiri, juriya na insulin, da sauransu. A asibiti, ana siffanta shi da farko ta hyperglycemia. Yawancin lokuta na iya kasancewa tare da polyuria, polydipsia, polyphagia, da asarar nauyi, wanda aka sani da alamun "polys guda uku da asara daya". An rarraba shi a asibiti zuwa nau'in ciwon sukari na 1, nau'in ciwon sukari na 2, ciwon sukari na ciki, da sauran takamaiman nau'ikan ciwon sukari.

Abubuwan Gane Ciwon Ciwon Suga

Islet autoantibodies alamomin lalata-tsakiya ta hanyar rigakafi na ƙwayoyin β pancreatic kuma sune mahimman alamomi don gano ciwon sukari na autoimmune. Glutamic acid decarboxylase antibodies (GAD), tyrosine phosphatase antibodies (IA-2A), insulin antibodies (IAA), da islet cell antibodies (ICA) sune mahimman alamomin rigakafi don gano asibiti na ciwon sukari.

Nazarin da yawa sun nuna cewa haɗuwa da ganowa zai iya inganta yawan gano ciwon sukari na autoimmune. Mafi girman adadin ingantattun ƙwayoyin rigakafin da ke gabatarwa da wuri, mafi girman haɗarin mutum ya ci gaba da sauri zuwa ciwon sukari na asibiti.

Bincike ya nuna:

Mutanen da ke da ƙwayoyin rigakafi guda uku ko fiye suna da haɗarin > 50% na kamuwa da ciwon sukari na Type 1 a cikin shekaru 5.

Mutanen da ke da ƙwayoyin rigakafi guda biyu suna da haɗarin 70% na haɓaka nau'in ciwon sukari na 1 a cikin shekaru 10, 84% a cikin shekaru 15, kuma kusan 100% suna ci gaba zuwa nau'in ciwon sukari na 1 bayan shekaru 20 na biyo baya.

Mutanen da ke da maganin rigakafi guda ɗaya suna da haɗarin 14.5% kawai na kamuwa da ciwon sukari na Type 1 a cikin shekaru 10.

Bayan bayyanar ƙwayoyin rigakafi masu kyau, ƙimar ci gaba zuwa nau'in ciwon sukari na 1 yana da alaƙa da nau'ikan ƙwayoyin rigakafi masu kyau, shekarun bayyanar antibody, jinsi, da HLA genotype.

Beier Yana Bada Cikakken Gwajin Ciwon Ciwon sukari

Dabarun jerin samfuran ciwon sukari na Beier sun haɗa da Chemiluminescence Immunoassay (CLIA) da Enzyme-Linked Immunosorbent Assay (ELISA). Haɗin gano alamun halittu suna taimakawa a farkon ganowa, sarrafa lafiya na farko, da farkon jiyya na ciwon sukari, don haka inganta alamun lafiyar ɗan adam.

Magana:

1. Societyungiyar rashin lafiyar Sin, da likitan likitanci na kasar Sin, ta hanyar al'ummar kasar Sin, al'ummar intanetcrinology, et al. Jagora don ganowa da kuma kula da nau'in ciwon sukari na 1 a China (bugu na 2021) [J]. Jaridar Sinanci na Ciwon sukari mellitus, 2022, 14 (11): 1143-1250. DOI: 10.3760/cma.j.cn115791-20220916-00474.

2. Kungiyar likitocin mata ta kasar Sin kwamitin kwararrun masu fama da ciwon sukari, Kwamitin Edita na Jaridar Gudanar da Lafiya ta kasar Sin, Gidauniyar Inganta Lafiya ta kasar Sin. Ijma'in ƙwararru kan bincike da shiga tsakani ga yawan masu fama da ciwon sukari a China. Jaridar Sinanci na Gudanar da Lafiya, 2022, 16 (01): 7-14. DOI: 10.3760/cma.j.cn115624-20211111-00677.